Genoway (ALGEN) — Capital Reinvestment Ratio

Latest as of December 2024: 0.44x

Genoway (ALGEN) has a Capital Reinvestment Ratio of 0.44x as of December 2024, meaning it reinvests 0% of its operating cash flow (€5.38 Million) in capital expenditures (€2.39 Million). See debt-free asset ratio of Genoway to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.44x
Capex / Operating Cash Flow

Operating Cash Flow

€5.38 Million
EUR

Capital Expenditures

€2.39 Million
EUR

Data as of

Dec 2024
Most recent filing

Genoway Capital Reinvestment Ratio (2009–2024)

This chart tracks Genoway's Capital Reinvestment Ratio across 12 annual periods. Check Genoway cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Genoway (2009–2024)

Year-by-year Capital Reinvestment Ratio for Genoway from 2009 to 2024. For live market cap and broader valuation context, see Genoway stock valuation.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2024 0.44x €5.38 Million €2.39 Million ▼ -23.8%
2023 0.58x €3.06 Million €1.78 Million ▼ -28.5%
2022 0.81x €2.36 Million €1.92 Million ▼ -64.5%
2019 2.29x €1.18 Million €2.70 Million ▼ -28.2%
2018 3.19x €847.03K €2.70 Million ▼ -26.7%
2017 4.35x €620.94K €2.70 Million ▲ +2200.5%
2015 0.19x €851.08K €161.06K ▼ -20.5%
2014 0.24x €200.29K €47.66K ▲ +102.1%
2013 0.12x €852.87K €100.41K ▼ -65.7%
2011 0.34x €741.51K €254.35K ▼ -12.2%
2010 0.39x €914.07K €357.19K ▲ +14034.6%
2009 0.00x €1.80 Million €4.98K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow